SCI Pharmtech Inc (4119) — Cash Flow Reinvestment Rate
SCI Pharmtech Inc (4119) has a Cash Flow Reinvestment Rate of 0.39x as of June 2026, reinvesting NT$60.99 Million (capex NT$60.99 Million ) from operating cash flow of NT$156.75 Million. See 4119 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SCI Pharmtech Inc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for SCI Pharmtech Inc across 23 annual periods. For the full cash flow conversion analysis, see 4119 cash flow conversion.
Annual Cash Flow Reinvestment Rate for SCI Pharmtech Inc (2002–2025)
Year-by-year capital reinvestment analysis for SCI Pharmtech Inc. See SCI Pharmtech Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.21x | NT$707.54 Million | NT$220.32 Million | NT$610.00 Million | ▲ +183.7% |
| 2024 | 1.13x | NT$974.05 Million | NT$860.52 Million | NT$946.64 Million | ▼ -87.1% |
| 2023 | 8.79x | NT$1.90 Billion | NT$215.77 Million | NT$1.03 Billion | ▲ +19.7% |
| 2022 | 7.34x | NT$2.18 Billion | NT$296.56 Million | NT$1.17 Billion | ▲ +103.2% |
| 2021 | 3.61x | NT$1.01 Billion | NT$280.28 Million | NT$774.98 Million | ▲ +706.1% |
| 2020 | 0.45x | NT$435.34 Million | NT$971.53 Million | NT$217.70 Million | ▲ +32.5% |
| 2019 | 0.34x | NT$267.76 Million | NT$791.60 Million | NT$204.49 Million | ▼ -21.2% |
| 2018 | 0.43x | NT$206.20 Million | NT$480.18 Million | NT$162.44 Million | ▼ -55.9% |
| 2017 | 0.97x | NT$273.96 Million | NT$281.65 Million | NT$147.39 Million | ▲ +16.8% |
| 2016 | 0.83x | NT$418.32 Million | NT$502.11 Million | NT$177.20 Million | ▲ +15.5% |
| 2015 | 0.72x | NT$478.51 Million | NT$663.24 Million | NT$217.51 Million | ▼ -44.0% |
| 2014 | 1.29x | NT$462.15 Million | NT$358.77 Million | NT$369.15 Million | ▼ -62.8% |
| 2013 | 3.46x | NT$826.27 Million | NT$238.57 Million | NT$773.01 Million | ▲ +638.2% |
| 2012 | 0.47x | NT$180.90 Million | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$147.71 Million | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$190.34 Million | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$181.13 Million | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$138.12 Million | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.21 Million | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$162.00 Million | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$35.55 Million | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$100.29 Million | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$41.73 Million | NT$107.12 Million | NT$41.73 Million | — |